Vertex Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
CEOReshma Kewalramani
CEOReshma Kewalramani
Employees5,400
Employees5,400
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded1989
Founded1989
Employees5,400
Employees5,400
VRTX Key Statistics
Market cap116.18B
Market cap116.18B
Price-Earnings ratio-226.38
Price-Earnings ratio-226.38
Dividend yield—
Dividend yield—
Average volume1.48M
Average volume1.48M
High today$451.76
High today$451.76
Low today$445.38
Low today$445.38
Open price$449.08
Open price$449.08
Volume1.65M
Volume1.65M
52 Week high$519.88
52 Week high$519.88
52 Week low$346.29
52 Week low$346.29
VRTX News
Seeking Alpha 7d
Gilead, Vertex initiated as new big biotech buys at CitiCiti has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth...
Analyst ratings
57%
of 37 ratingsBuy
56.8%
Hold
35.1%
Sell
8.1%